Allosteric modulation of A3 adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives

Molecular Pharmacology

Volumn 60, Issue 5, 2001, Pages 1057-1063

  Gao, Zhan Guo ^a,b   Van Muijlwijk Koezen, Jacqueline E ^b   Chen, Aishe ^a   Müller, Christa E ^c   Ijzerman, Adriaan P ^b   Jacobson, Kenneth A ^a,d  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3 (2 PYRIDINYL)ISOQUINOLINE DERIVATIVE; 4 METHOXY N [3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZAMIDE; 4 METHOXY N [3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZENECARBOXIMIDAMIDE; 4 METHOXY N [7 METHYL 3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZAMIDE; 4 METHYL N [3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZAMIDE; 4 METHYL N [3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZENECARBOXIMIDAMIDE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ISOQUINOLINE DERIVATIVE; N [3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZAMIDE; N [3 (2 PYRIDINYL) 1 ISOQUINOLINYL]BENZENECARBOXIMIDAMIDE; N6 (4 AMINO 3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; UNCLASSIFIED DRUG; VUF 8501; VUF 8502; VUF 8503; VUF 8504; VUF 8505; VUF 8507;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING COMPETITION; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION; DRUG RECEPTOR BINDING; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; STRUCTURE ACTIVITY RELATION;

EID: 0034764185     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.5.1057     Document Type: Article

References (38)

1. 1 adenosine receptors
2. Allosteric regulation of G-protein-linked receptors
3. Multiple allosteric sites on muscarinic receptors
4. 1 receptor binding and function by 2-amino-3-benzoylthiophenes
5. Allosteric interactions at muscarinic cholinoceptors
6. 2+-sensing receptor
7. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips
8. Structure and function of adenosine receptors and their genes
9. 2A adenosine receptors by amiloride analogues and sodium ions
10. 278 in ligand binding and sodium modulation
11. Inhibition of oxytocin receptor function by direct binding of progesterone
12. 3 receptor-mediated hypotension in the rat
13. 4 dopamine receptors by amiloride and amiloride analogues
14. Allosteric modulators of ligand binding to muscarinic acetylcholine receptors
15. Activation of muscarinic acetylcholine receptors via their allosteric binding sites
16. Adenosine receptors as potential therapeutic targets
17. Allosteric interaction of heparin with NK-1 receptors in rat striatal membranes
18. Allosteric activation of CaR by L-amino acids
19. 1 receptors
20. 1 receptor
21. 3 receptors
22. 1A-adrenergic receptor
23. Allosteric enhancement of adenosine receptors
24. CPCCOEt, a noncompetitive metabotropic glutamate receptor antagonist, inhibits receptor signaling without affecting glutamate binding
25. 3 receptor
26. 3 adenosine receptor antagonists
27. 2 receptors, is a spin trapping agent
28. 3 adenosine receptor
29. 1) receptor
30. 3 adenosine receptors
31. Measurement of protein using bicinchoninic acid
32. 3 receptors
33. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide
34. 2 receptors
35. Allosteric modulation of muscarinic acetylcholine receptors
36. 3 receptor ligands. 1.3-(2-Pyridinyl)isoquinoline derivatives
37. 3 receptor stimulation and cerebral ischemia
38. 3 adenosine receptor